Table 2.
Parameters of patients during the study.
| Time points | |||
|---|---|---|---|
| Baseline | Month 3 | Month 6 | |
| Albumin/creatinine ratio | |||
| Case | 60.69 ± 22.04 | 56.98 ± 25.28 | 59.37 ± 28.24 |
| Control | 63.87 ± 23.26 | 64.51 ± 31.27 | 64.63 ± 27.86 |
| P value | 0.77 | 0.41 | 0.58 |
| Systolic blood pressure | |||
| Case | 115.68 ± 11.16 | 117.73 ± 9.72 | 114.32 ± 11.37 |
| Control | 115.28 ± 9.15 | 115.28 ± 11.17 | 112.50 ± 11.15 |
| P value | 0.90 | 0.46 | 0.61 |
| Diastolic blood pressure | |||
| Case | 75.45 ± 8.15 | 76.50 ± 5.72 | 75 ± 5.34 |
| Control | 77.29 ± 8.26 | 77.22 ± 6.69 | 77.50 ± 8.44 |
| P value | 0.50 | 0.88 | 0.26 |
| Glomerular filtration rate | |||
| Case | 73.93 ± 1.05 | — | 73.05 ± 11.80 |
| Control | 71.54 ± 9.29 | — | 80.22 ± 11.97 |
| P value | 0.45 | — | 0.06 |
Data expressed as mean ± SD.
Case group included patients who received regular medications plus 400 mg pentoxifylline. Control group included patients who received regular medications plus placebo.
P values calculated by Independent Samples Test.